Notably, KLK6 is further lowered in CSF of clinically definite MS patients as compared to clinically isolated syndrome, perhaps due to the proximity to clinical attacks or demyelinating lesions at the time of sample collection [32]. The gene discussed is KLK6; the disease is myeloid sarcoma.